Category: H1 Receptors

Although the risk is low especially for the majority of thrombocytopenic patients who need long-term platelet transfusions (immunosuppressive therapy, malignancies), it could have a clinical impact in childbearing age women, when RhD alloimmunization can cause hemolytic disease of the fetus and newborn

Although the risk is low especially for the majority of thrombocytopenic patients who need long-term platelet transfusions (immunosuppressive therapy, malignancies), it could have a clinical […]

Continue reading